in [221]) as highlighted by a study from Zhu et al. who showed that activation of cannabinoid receptors by Δ9-THC inhibited anti-tumor immunity through an CB2-mediated increase in tumor promoting cytokines [36]. Here, CNR2 is linked to neoplasm.